Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy
Advances in cancer therapeutics have improved patient survival rates. However, cancer
survivors may suffer from adverse events either at the time of therapy or later in life …
survivors may suffer from adverse events either at the time of therapy or later in life …
High risk of non-cancer mortality in bladder cancer patients: Evidence from SEER-Medicaid
S Wang, C Ge - Journal of Cancer Research and Clinical Oncology, 2023 - Springer
Purpose The objective of this study was to investigate non-cancer causes of death and
associated risk factors after bladder cancer (BC) diagnosis. Methods Eligible BC patients …
associated risk factors after bladder cancer (BC) diagnosis. Methods Eligible BC patients …
Trends in the cause of death among patients with bladder cancer in the US SEER population, 1992–2018
X Zhan, L Chen, M Jiang, B Fu - World Journal of Urology, 2022 - Springer
Background Bladder cancer (BC) survival has shown no significant improvement. This study
investigated the trends in the common causes of death among patients with BC to improve …
investigated the trends in the common causes of death among patients with BC to improve …
The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: a SEER population-based analysis
Q Lin, JH Bao, F Xue, JJ Qin, Z Chen, ZR Chen… - Frontiers in …, 2022 - frontiersin.org
Background Despite improved overall survival outcomes, chemotherapy has brought
concerns for heart disease–related death (HDRD) among cancer patients. The effect of …
concerns for heart disease–related death (HDRD) among cancer patients. The effect of …